Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Éric Pujade-Lauraine, Frédèric Selle, Giovanni Scambia, Bernard Jean Roger Asselain, Frederik Marmé, Kristina Yvonne Lindemann and 17 more

Rank
26 of 3,639
Percentile
top 0.8%
Where
Annals of Oncology, 2023
Citations
119

From the 2023 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.